Idexx Laboratories Inc (IDXX) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Idexx Laboratories Inc  (NASDAQ: IDXX)
 

Idexx Laboratories Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Idexx Laboratories Inc inventory turnover ratio, the Idexx Laboratories Inc's ability to sell and replace its inventory in the third quarter 2026, sequentially increased to 4.51 in the third quarter 2026, IDXX's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Idexx Laboratories Inc in Sep 30 2026 quarter, has decreased to 81 days, compare to 82 days, in the Jun 30 2026 quarter.

Within Healthcare sector 83 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 438 in the second quarter 2026, to 895.

IDXX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Idexx Laboratories Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IDXX Inventory Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Inventory Growth -0.18 % -0.26 % -3.43 % -1.08 % 0.45 %
Y / Y Cost of Sales Growth 6.87 % 5.68 % 11.47 % 13.02 % 11.08 %
Inventory Turnover Ratio (TTM) 4.51 4.43 4.37 4.22 4.08
IDXX's Total Ranking # 895 # 438 # 438 # 438 #
Average inventory processing period 81 82 84 86 89
Seq. Inventory Growth -0.18 % 2.4 % 1.23 % -3.53 % -0.26 %
Seq. Cost of Sales Growth 2.84 % 4.66 % -3.69 % 3.09 % 1.69 %




Inventory Turnover Ratio Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 3
Healthcare Sector # 84
Overall Market # 895

Inventory Turnover Ratio Statistics
High Average Low
5.61 4.44 3.14
(Jun 30 2021)   (Sep 30 2012)



IDXX Company Profile >> Back to IDXX Efficiency Comparisons >> Compare IDXX Inventory Turnover Ratio to its Competitors

Financial Statements
Idexx Laboratories Inc's Inventories $ 391 Millions Visit IDXX's Balance sheet
Idexx Laboratories Inc's Cost of Revenues TTM $ 1,739 Millions Visit IDXX's Income Statement
What are IDXX's Sales? Visit IDXX's Sales by Segment

Other Inventory Turnover Ratios
Idexx Laboratories Inc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
In Vitro & In Vivo Diagnostic Substances Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
IDXX's Inventory Turnover Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for IDXX's Competitors
Inventory Turnover Ratio for IDXX's Suppliers
Inventory Turnover Ratio for IDXX's Customers

You may also want to know
IDXX's Sales Growth Rates IDXX's Pe Price to earnings ratio IDXX's Receivables Turnover Ratio IDXX's Stock Quote
IDXX's Net Income Growth Rates IDXX's Ps Price to Sales ratio IDXX's Sales per Employee IDXX's Asset Turnover Ratio
IDXX's Net Margin IDXX's Pb Price to Book ratio IDXX's Financial Strength Ratios IDXX's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Brightspring Health Services Inc   11.57 $ 7,583.638  Millions$ 655  Millions
Vanda Pharmaceuticals Inc   8.70 $ 14.704  Millions$ 2  Millions
Phathom Pharmaceuticals Inc   7.76 $ 53.106  Millions$ 7  Millions
Carlisle Companies Incorporated  6.99 $ 3,406.400  Millions$ 488  Millions
Caredx Inc   6.42 $ 111.106  Millions$ 17  Millions
Bristol myers Squibb Company  5.65 $ 15,389.000  Millions$ 2,722  Millions
Avantor Inc   5.48 $ 4,539.200  Millions$ 828  Millions
Integer Holdings Corporation  4.98 $ 1,376.268  Millions$ 276  Millions
Ge Healthcare Technologies Inc   4.69 $ 11,372.000  Millions$ 2,425  Millions
West Pharmaceutical Services Inc   4.69 $ 2,120.200  Millions$ 452  Millions
Medinotec Inc   4.28 $ 5.143  Millions$ 1  Millions
3m Company  4.02 $ 15,267.000  Millions$ 3,801  Millions
Novocure Limited  3.98 $ 166.721  Millions$ 42  Millions
Incyte Corporation  3.79 $ 439.399  Millions$ 116  Millions
Baxter International Inc   3.57 $ 8,117.000  Millions$ 2,277  Millions
Bausch Health Companies Inc   3.54 $ 4,518.000  Millions$ 1,276  Millions
Exelixis Inc   3.49 $ 93.324  Millions$ 27  Millions
Gilead Sciences Inc   3.30 $ 6,219.000  Millions$ 1,884  Millions
Mimedx Group Inc   2.98 $ 70.562  Millions$ 24  Millions
Ligand Pharmaceuticals Incorporated  2.93 $ 34.495  Millions$ 12  Millions
Neogen Corporation  2.89 $ 464.774  Millions$ 161  Millions
Biomerica Inc   2.65 $ 4.297  Millions$ 2  Millions
Dexcom Inc   2.65 $ 1,867.500  Millions$ 705  Millions
Angiodynamics Inc   2.50 $ 142.709  Millions$ 57  Millions
Pro dex Inc   2.45 $ 53.753  Millions$ 22  Millions
Illumina Inc   2.36 $ 1,458.000  Millions$ 618  Millions
Resmed Inc   2.33 $ 2,214.675  Millions$ 952  Millions
Beta Bionics Inc   2.31 $ 53.285  Millions$ 23  Millions
Merit Medical Systems Inc  2.25 $ 817.001  Millions$ 363  Millions
Johnson and Johnson  2.17 $ 32,222.000  Millions$ 14,824  Millions

Date modified: 2026-11-03T06:25:04+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.